Siemens Healthineers AG (LTS:0PMJ) GF Score: 79/100 (As of Jul. 11, 2026) — Near Median


LTS:0PMJ Siemens Healthineers AG LTS:0PMJ
79 GF Score
Price €34.55
GF Value €52.22
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Siemens Healthineers AG GF Score?

Siemens Healthineers AG LTS:0PMJ +0.45% 79 GF Score is 79 as of Jul. 11, 2026, which is 1% above its 10-year median of 78.00. GuruFocus rates LTS:0PMJ with a GF Score™ of 79/100 and a GF Value™ of €52.22 (Possible Value Trap). The stock has 5 warning signs investors should review.

Siemens Healthineers AG has the GF Score of 79, which implies that the company is Likely to have average performance.

The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.

GF Score takes following five key aspects into consideration:

1. Financial Strength : 7/10
2. Profitability Rank : 7/10
3. Growth Rank : 7/10
4. GF Value Rank : 4/10
5. Momentum Rank : 4/10

Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.

Based on research and backtesting result, GuruFocus believes Siemens Healthineers AG is Likely to have average performance.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.


Siemens Healthineers AG  (LTS:0PMJ) GF Score Explanation

Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:

GF Score Performance Potential and All-in-One Screener Examples (1)
91 - 100Highest outperformance potential
81 - 90Good outperformance potential
71 - 80Likely to have average performance
51 - 70Poor future performance potential
0 - 50Worst future performance potential, or not enough data

(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.


Siemens Healthineers AG GF Score Related Terms


LTS:0PMJ vs ABT, SYK, MDT: GF Score Comparison

For the Medical Devices subindustry, Siemens Healthineers AG's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Siemens Healthineers AG GF Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Siemens Healthineers AG's GF Score distribution charts can be found below:

* The bar in red indicates where Siemens Healthineers AG's GF Score falls into.


LTS:0PMJ
79GF Score
Siemens Healthineers AG LTS:0PMJ
GF Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about GF Score →
What does a GF Score of 79 mean?
Siemens Healthineers AG (LTS:0PMJ) has a GF Score of 79 as of Jul. 11, 2026. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Siemens Healthineers AG and its competitors. This is near median its historical median of 78.00. Over the past decade, Siemens Healthineers AG's GF Score has ranged from 19.00 to 91.00.
Is Siemens Healthineers AG's GF Score too high?
Siemens Healthineers AG's current GF Score of 79 is near median its 10-year median of 78.00. Over the past 10 years, this metric has ranged from a low of 19.00 to a high of 91.00. Overall, Siemens Healthineers AG has a GF Score™ of 79/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Siemens Healthineers AG's GF Score compare to ABT and SYK?
Siemens Healthineers AG's GF Score of 79 can be compared against companies in the Medical Devices & Instruments industry. Historically, Siemens Healthineers AG's own GF Score has ranged from 19.00 to 91.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Score for a Medical Devices & Instruments company?
A good GF Score depends on the Medical Devices & Instruments industry context. However, GF Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Score mean?
A high GF Score can signal that a stock is expensive relative to its fundamentals. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Siemens Healthineers AG and its competitors. Siemens Healthineers AG's current GF Score is 79, which is near median its own 10-year median of 78.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Siemens Healthineers AG stock overvalued right now?
Based on GuruFocus' analysis, Siemens Healthineers AG (LTS:0PMJ) is currently considered Possible Value Trap. The stock's GF Value™ is €52.22, compared to a current price of €34.55 — trading 33.8% below its estimated fair value. The current GF Score is 79, which is near median its 10-year median of 78.00. Siemens Healthineers AG's overall GF Score™ is 79/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Score calculated?
GF Score is calculated from a company's financial statements. For Siemens Healthineers AG (LTS:0PMJ), the current GF Score is 79 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Siemens Healthineers AG (LTS:0PMJ) Overvalued in 2026?

Based on GuruFocus' analysis, Siemens Healthineers AG stock appears to be undervalued. The current stock price of €34.55 is trading 33.8% below its estimated GF Value™ of €52.22. GuruFocus considers Siemens Healthineers AG to be Possible Value Trap.

Key valuation signals for LTS:0PMJ:

  • GF Score: 79 (near median its 10-year median of 78.00)
  • GF Value™: €52.22 vs. price of €34.55 (33.8% below fair value)
  • GF Score™: 79/100 with 5 warning signs

No single metric tells the full story. See the LTS:0PMJ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Siemens Healthineers AG Business Description

Address Siemensstrasse 3, Forchheim, BY, DEU, 91301
Siemens Healthineers is engaged in therapeutic imaging, radiotherapy, laboratory, and point-of-care diagnostics. The imaging segment (56% of sales in fiscal 2025) includes magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound. The Varian segment (18% of sales) offers radiotherapy and other oncology solutions. The diagnostics segment (19%) includes in vitro diagnostics and point-of-care diagnostics. The advanced therapies (now part of precision therapy) segment (9%) products are designed to support image-guided minimally invasive treatments in cardiology, interventional radiology, and surgery. The Americas represents 44% of total sales, Europe, Middle East, and Africa 32%, and Asia-Pacific, including China (11%), the remainder.
79GF Score

Get the complete analysis for LTS:0PMJ

GF Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€34.55
Price
€52.22
GF Value